Cargando…
MCT4/Lactate Promotes PD-L1 Glycosylation in Triple-Negative Breast Cancer Cells
Triple-negative breast cancer (TNBC) has the highest percentage of lymphocytic infiltration among breast cancer subtypes, and TNBC patients may benefit from anti-PD-1/PD-L1 immunotherapy. However, some cases whether the immune checkpoint blockade (ICB) shows low targeting efficiency have occurred an...
Autores principales: | Duan, Xianxian, Xie, Yu, Yu, Jing, Hu, Xiao, Liu, Zhanzhao, Li, Ning, Qin, Junfang, Lan, Lan, Yuan, Mengci, Pan, Zhanyu, Wang, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529401/ https://www.ncbi.nlm.nih.gov/pubmed/36199799 http://dx.doi.org/10.1155/2022/3659714 |
Ejemplares similares
-
Downregulation of MCT4 for lactate exchange promotes the cytotoxicity of NK cells in breast carcinoma
por: Long, Yaping, et al.
Publicado: (2018) -
Tissue expression of lactate transporters (MCT1 and MCT4) and prognosis of malignant pleural mesothelioma (brief report)
por: Dell’Anno, Irene, et al.
Publicado: (2020) -
Critical Velocity, Maximal Lactate Steady State, and Muscle MCT1 and MCT4 after Exhaustive Running in Mice
por: Orsi, Juan B., et al.
Publicado: (2023) -
MCT1 and MCT4 Expression and Lactate Flux Activity Increase During White and Brown Adipogenesis and Impact Adipocyte Metabolism
por: Petersen, Charlotte, et al.
Publicado: (2017) -
Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD+ Depletion in Cancer Cells
por: Benjamin, Don, et al.
Publicado: (2018)